This free and easy to use program provides cancer survivors with information regarding the health risks they face as a result of cancer therapies.
What is it? How do I get one?
This is award winning video is presented courtesy of the Institute of Medicine (IOM).
American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008
American Cancer Society. Cancer Treatment and Survivorship Facts & Figures 2014-2015. Atlanta: American Cancer Society; 2014.
(2006). "Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients. " J Support Oncol 4(2): 66-7.
(2004)."A National Action Plan for Cancer Survivorship: Advancing Public Health Strategies" Centers for Disease Control and Prevention and the Lance Armstrong Foundation (accessed online).
(2004). "Cancer survivorship--United States, 1971-2001. " MMWR Morb Mortal Wkly Rep 53 (24): 526-9.
(2007). "Coming together to improve care. " Am J Nurs 107 (4): 66.
Aapro, M., Bernard-Marty, C., Brain, E.G., Batist. G., Erdkamp, F., Krzemieniecki, K., Leonard, R., Lluch, A., Monfardini, S., Ryberg, M., Soubeyran, P., Wedding, U. (2011). Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Annals of Oncology, 22(2), 257-267.
Abou-Mourad, YR et al. (2009) Long-term outcome after Allo-SCT: close follow-up on a large cohort treated with myeloablative regimens. Bone Marrow Transplantation; advance online publication 13 July 2009.
Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease.J Clin Oncol.2003;21:3431-9.
Ahles, T.A.and A.J. Saykin (2007). "Cand idate mechanisms for chemotherapy-induced cognitive changes. " Nat Rev Cancer 7(3): 192-201.
Alfano, C. M. and J. H. Rowland (2006). "Recovery issues in cancer survivorship: a new challenge for supportive care." Cancer J 12(5): 432-43.
Baker, F., M. Denniston, et al. (2005). "Adult cancer survivors: how are they faring?" Cancer 104 (11 Suppl): 2565-76.
Baker KS, et al. (2007) Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 109: 1765–1772.
Barry, E., Alvarez, J.A., Scully, R.E., Miller, T.L., Lipshultz, S.E. (2007). Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opinion on Pharmacotherapy, 8(8):1039-1058.
Baum, M., A. Buzdar, et al. (2003). "Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses." Cancer 98 (9): 1802-10.
Beasley, G. M., Caudle, A., Petersen, R. P., McMahon, N. S., Padussis, J., Mosca, P. J., et al. (2009). A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg, 208(5), 706-715; discussion 715-707.
Bexxar: Package Insert
Bhatia S, Yasui Y, Robison LL, High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.J Clin Oncol.2003;21:4386-94.
Bokemeyer, C., C.C. Berger, et al. (1996). "Evaluation of long-term toxicity after chemotherapy for testicular cancer." J Clin Oncol 14 (11): 2923-32.
Bower, J.E.(2005). "Prevalence and Causes of Fatigue After Cancer Treatment: The Next Generation of Research." J Clin Oncol 23 (33): 8280-8282.
Braun, I. M., D. B. Greenberg, et al. (2008). "Evidenced-based report on the occurrence of fatigue in long-term cancer survivors." J Natl Compr Canc Netw 6(4): 347-54.
Brigden, M. L. (2001). Detection, education and management of the asplenic or hyposplenic patient. Am Fam Physician, 63(3), 499-506, 508.
Buchegger, F., Antonescu, C., Delaloye, A.B., Helg, C., Kovacsovics, T., Kosinski, M., Mach, J.P., Ketterer, N. (2006). Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma. British Journal of Cancer, 94(12):1770-1776.
Buzdar, A.U.(2004). "Data from the Arimidex, tamoxifen, alone or in combination ( ATAC ) trial: implications for use of aromatase inhibitors in 2003. " Clin Cancer Res 10 (1 Pt 2): 355S-61S.
Camp-Sorrell, D.(2006). "Cardiorespiratory effects in cancer survivors.Cardiac and pulmonary toxicities may occur as late or long-term sequelae of cancer treatment. " Am J Nurs 106 (3 Suppl): 55-9.
Cannon, G.W.(1997). "Methotrexate pulmonary toxicity. " Rheum Dis Clin North Am 23 (4): 917-37.
Cardous-Ubbink, M.C., R.C.Heinen, et al. (2004). "Long-term cause-specific mortality among five-year survivors of childhood cancer. " Pediatr Blood Cancer 42 (7): 563-73.
Carver, J.R., C.L. Shapiro, et al. (2007). "American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects." J Clin Oncol.
Carver, J.R., Shapiro, C.L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K.S., Hagerty, K.L,. Somerfield, M.R., Vaughn, D.J.; ASCO Cancer Survivorship Expert Panel. (2007). American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. Journal of Clinical Oncology, 25(25):3991-4008.
Chaudhary UB, Haldas JR.Long-term complications of chemotherapy for germ cell tumours.Drugs.2003;63:1565-77.
Coletta, E. M. (2000). Care of the elderly patient with lower extremity amputation. J Am Board Fam Pract, 13(1), 23-34.
Demark-Wahnefried, W., B.M. Pinto, et al. (2006). "Promoting health and physical function among cancer survivors: potential for prevention and questions that remain." J Clin Oncol 24 (32): 5125-31.
Deniz K, O'Mahony S, Ross G, et al. Breast cancer in women after treatment for Hodgkin's disease.Lancet Oncol.2003;4:207-14.
Di Sabatino, A., Carsetti, R., & Corazza, G. R. Post-splenectomy and hyposplenic states. Lancet, 378(9785), 86-97.
Doyle, J.J., A.I. Neugut, et al. (2005). "Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study." J Clin Oncol 23 (34): 8597-605.
Earle, C.C.(2006). "Failing to plan is planning to fail: improving the quality of care with survivorship care plans." J Clin Oncol 24 (32): 5112-6.
Earle, C. C., & Neville, B. A. (2004). Under use of necessary care among cancer survivors. Cancer, 101(8), 1712-1719.
Elisaf, M.S., E.T. Bairaktari, et al. (2001). "Effect of letrozole on the lipid profile in postmenopausal women with breast cancer. " Eur J Cancer 37 (12): 1510-3.
Feuerstein, M.(2005). "Cancer survivorship and work. " J Occup Rehabil 15 (1): 1-2.
Folotyn Package Insert
Fossa, S.D.(2004). "Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer. " Acta Oncol 43 (2): 134-41.
Friedman, D.L., A. Rovo, et al. (2008). "Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party." Blood 111(2): 939-44.
Friedman, D.L. and L.S. Constine (2006). "Late effects of treatment for Hodgkin lymphoma. " J Natl Compr Canc Netw 4 (3): 249-57.
Ganz, P.A.(2006). "Monitoring the physical health of cancer survivors: a survivorship-focused medical history." J Clin Oncol 24 (32): 5105-11.
Ganz, P.A., C.M. Moinpour, et al. (2003). "Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133." J Clin Oncol 21 (18): 3512-9.
Ganz, P.A. and E.E. Hahn (2008). "Implementing a survivorship care plan for patients with breast cancer." J Clin Oncol 26(5): 759-67.
Ganz, P.A., M.A. Hussey, et al. (2008). "Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897." J Clin Oncol 26(8): 1223-30.
Garcia-Rodriguez, M.J., Canales, M.A., Hernandez-Maraver, D., Hernandez-Navarro, F. (2008). Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment? American Journal of Hematology, 83(8):673-675.
Genetic Testing for Hereditary Cancer Syndromes. National Cancer Institute; 2013 Apr 11. Available from: http://www.cancer.gov/cancertopics/genetics/genetic-testing-fact-sheet
Gerharz EW et al. (2003) Metabolic and functional consequences of urinary reconstruction with bowel. BJU International 91(2): 143-149.
Gilbert D et al. (2009) “Reducing treatment toxicities in the management of good prognosis testicular cancer.” Expert Review of Cancer Therapy 9(2): 223-233.
Gilbert, DC et al. (2009) Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors. Expert Reviews in Anticancer Therapy 9(2): 223-228.
Gospodarowicz, M.(2008). Testicular cancer patients: considerations in long-term follow-up. Hematology Oncology Clinics of North America, 22(2):245-255, vi.
Greving, D.M.and S.J. Santacroce (2005). "Cardiovascular late effects. " J Pediatr Oncol Nurs 22 (1): 38-47.
Grunfeld, E.(2005). "Cancer survivorship: a challenge for primary care physicians. " Br J Gen Pract 55 (519): 741-2.
Grunfeld, E.(2006). "Looking beyond survival: how are we looking at survivorship?" J Clin Oncol 24 (32): 5166-9.
Guidry, J.J., W. Torrence, et al. (2005). "Closing the divide: diverse populations and cancer survivorship. " Cancer 104 (11 Suppl): 2577-83.
Haddy, T.B., M.A. Adde, et al. (1998). "Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas." J Clin Oncol 16 (6): 2070-9.
Hanson, K. (2006). "State cancer survivorship policies." NCSL Legisbrief 14(47): 1-2.
Hawkins, R.(2006). "Osteoporosis.Cancer survivors are at increased risk for osteoporosis, but how their management differs from that of the general population remains unclear. " Am J Nurs 106 (3 Suppl): 78-82.
Haylock, P.J., S.A. Mitchell, et al. (2007). "The Cancer Survivor's Prescription for Living. " Am J Nurs 107 (4): 58-70.
Heidenreich, PA et al. Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease.Journal of Clinical Oncology 2007;25:43-49.
Henderson, T.O., J. Whitton, et al. (2007). "Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study." J Natl Cancer Inst 99(4): 300-8.
Hequet, O., Q.H. Le, et al. (2004). "Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults." J Clin Oncol 22 (10): 1864-1871.
Herman, D.R., P.A. Ganz, et al. (2005). "Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study (CAMS). " Breast Cancer Res Treat 93 (1): 13-23.
Hodgson, DC (2008) Hodgkins Lymphoma: The Follow-Up of Long Term Survivors. Hematology / Oncology Clinics 22:233-244.
Hodgson, D. C., Grunfeld, E., Gunraj, N., & Del Giudice, L. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects. Cancer, 116(14), 3417-3425.
Hoffman, B.and E. Stovall (2006). "Survivorship perspectives and advocacy." J Clin Oncol 24 (32): 5154-9.
Houldin, A., C.P. Curtiss, et al. (2006). "Executive summary: The state of the science on nursing approaches to managing late and long-term sequelae of cancer and cancer treatment. " Am J Nurs 106 (3): 54-9.
Houldin, A., C.P. Curtiss, et al. (2006). "The state of the science on nursing approaches to managing late and long-term sequelae of cancer and cancer treatment. " Clin J Oncol Nurs 10 (3): 327-32.
Huddart, RA et al. (2005) Fertility, gonadal and sexual function in survivors of testicular cancer. British Journal of Cancer 93:200-207.
Hudson, M.M.(2005). "A model for care across the cancer continuum. " Cancer 104 (11 Suppl): 2638-42.
Institute of Medicine and the National Research Council (2005) "From Cancer Patient to Cancer Survivor: Lost in Transition" The National Academies Press, Washington, DC.
Istodax Package Insert
Jacene, H.A., Filice, R., Kasecamp, W., Wahl, R.L. (2007). Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice. Journal of Nuclear Medicine, 48(11):1767-1776.
Jansen, C.E., C. Miaskowski, et al. (2005). "A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. " Cancer 104(10): 2222-33.
Jensen, B.V.(2006). "Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer. " Semin Oncol 33 (3 Suppl 8): S15-21.
Johnson, S.A.(2006). "Anthracycline-induced cardiotoxicity in adult hematologic malignancies. " Semin Oncol 33 (3 Suppl 8): S22-7.
Jones, K.W.and S.R. Patel (2000). "A family physician's guide to monitoring methotrexate. " Am Fam Physician 62 (7): 1607-12, 1614.
Josting A, Wiedenmann S, Franklin J, Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.J Clin Oncol.2003;21:3440-6.
Kaufman, M.R. and S.S. Chang (2007). "Short- and long-term complications of therapy for testicular cancer." Urol Clin North Am 34(2): 259-68; abstract xi.
Keefe, D.L.(2001). "Anthracycline-induced cardiomyopathy. " Semin Oncol 28 (4 Suppl 12): 2-7.
Khan, N. F., Carpenter, L., Watson, E., & Rose, P. W. Cancer screening and preventative care among long-term cancer survivors in the United Kingdom. Br J Cancer, 102(7), 1085-1090.
Koya MP et al. (2006). “Complications of Intravesical Therapy for Urothelial Cancer of the Bladder.” The Journal of Urology 175: 2004-2010.
Lackner, JE et al. (2007) Hypogonadism and Androgen Deficiency Symptoms in Testicular Cancer Survivors. Urology 69(4):754-758.
Lamm, D. L., van der Meijden, A. P. M., Morales, A., Brosman, S. A., Catalona, W. J., Herr, H. W. et al: Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol, 147: 596, 1992
Lee, S.J., L.R. Schover, et al. (2006). "American Society of Clinical Oncology recommendations on fertility preservation in cancer patients." J Clin Oncol 24 (18): 2917-31.
Leigh, S.(2006). "Cancer survivorship: A first-person perspective.A nurse recounts her journey as patient, survivor, and advocate. " Am J Nurs 106 (3 Suppl): 12-4.
Leitao, M.M., Jr.and D.S. Chi (2005). "Fertility-sparing options for patients with gynecologic malignancies. " Oncologist 10 (8): 613-22.
Lockwood-Rayermann, S.(2006). "Survivorship issues in ovarian cancer: a review. " Oncol Nurs Forum 33 (3): 553-62.
Lowe, T et al (2007) Second malignancies after allogeneic hemapoietic cell transplant. Biology of Blood and Marrow Transplantation 13(10): 1121-1134.
Lubow, M., Grzybowski, D.M., Awad, H. (2008). Denilieukin diftitox vision loss is not posterior ischemic optic neuropathy. Leukemia & Lymphoma, 49(2):370-371; author reply 372.
Majhail, NS et al. (2007) Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biology of Blood & Marrow Transplantation 13(10): 1153-9.
Malcolm JB et al. (2009) Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy. BJU International 104(4): 476-481.
Manikantan K, et al. (2009). “Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up.” Cancer Treat Rev. 35(8):744-53.
McCaffrey, J.A.and H.I. Scher (1998). "Interstitial pneumonitis following bicalutamide treatment for prostate cancer. " J Urol 160 (1): 131.
Meadows, AT (2001) "Pediatric Cancer Survivors: Past History and Future Challenges." P repared in 2001 for the National Cancer Policy Board, Institute of Medicine (accessed online).
Meadows, A.T.(2006). "Pediatric Cancer Survivorship: Research and Clinical Care." J Clin Oncol 24 (32): 5160-5165.
Meinardi, M.T., J.A. Gietema, et al. (2000). "Cardiovascular morbidity in long-term survivors of metastatic testicular cancer." J Clin Oncol 18 (8): 1725-32.
Meinardi, M.T., J.A. Gietema, et al. (2000). "Long-term chemotherapy-related cardiovascular morbidity. " Cancer Treat Rev 26 (6): 429-47.
Michaud, L.B.and S. Goodin (2006). "Cancer-treatment-induced bone loss, part 1. " Am J Health Syst Pharm 63 (5): 419-30.
Michaud, L.B.and S. Goodin (2006). "Cancer-treatment-induced bone loss, part 2. " Am J Health Syst Pharm 63 (6): 534-46.
Moleski, M.(2000). "Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. " Arch Clin Neuropsychol 15(7): 603-30.
Mrozek, E. and C.L. Shapiro (2005). "Survivorship and complications of treatment in breast cancer." Clin Adv Hematol Onco l3(3): 211-22, 238.
Mukamel, E., Konichezky, M., Engelstein, D., Cytron, S., Abramavici, A. and Servadio, C.: Clinical and pathological findings in prostates following intravesical bacillus Calmette- Guerin instillations. J Urol, 144: 1399, 1990
Nayfield, S.G.and M.B. Gorin (1996). "Tamoxifen-associated eye disease.A review." J Clin Oncol 14 (3): 1018-26.
Nelson, M.B.and K. Meeske (2005). "Recognizing health risks in childhood cancer survivors. " J Am Acad Nurse Pract 17 (3): 96-103.
Nieman, C.L., R .Kazer, et al. (2006). "Cancer survivors and infertility: a review of a new problem and novel answers. " J Support Oncol 4 (4): 171-8.
Noorda, E. M., van Kreij, R. H., Vrouenraets, B. C., Nieweg, O. E., Muller, M., Kroon, B. B., et al. (2007). The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion. Eur J Surg Oncol, 33(6), 776-782.
Oeffinger, K.C., A.C. Mertens, et al. (2006). "Chronic health conditions in adult survivors of childhood cancer. " N Engl J Med 355 (15): 1572-82.
Oeffinger, K.C. and M. S. McCabe (2006). "Models for delivering survivorship care." J Clin Oncol 24(32): 5117-24.
Oktay, K.(2006). "An individualized approach to fertility preservation in women with cancer. " J Support Oncol 4 (4): 181-2, 184.
Ondrusova, M et al (2009) Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer. Neoplasma 56(6):473-479.
Pachler, J & Wille-Jørgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. 2004;(3)
Park, E. M., & Rosenstein, D. L. (2014). Living with advanced cancer: unmet survivorship needs. N C Med J, 75(4), 279-282.
Polomano, R.C.and J.T. Farrar (2006). "Pain and neuropathy in cancer survivors.Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. " Am J Nurs 106 (3 Suppl): 39-47.
Pozo, C. L., Morgan, M. A., & Gray, J. E. (2014). Survivorship issues for patients with lung cancer. Cancer Control, 21(1), 40-50.
Ram, R., Ben-Bassat, I., Shpilberg, O., Polliack, A., Raanani, P. (2009). The late adverse events of rituximab therapy--rare but there! Leukemia & Lymphoma, 50(7):1083-1095.
Rheingold, SR, Neugut, AI and AT Meadows (2003)."Secondary Cancers: Incidence, Risk Factors and Management" In Editors: Kufe, DW et.al.Cancer Medicine, 6 th ed., BC Decker, Ontario.
Riva, D., C. Giorgi, et al. (2002). "Intrathecal methotrexate affects cognitive function in children with medulloblastoma. " Neurology 59(1): 48-53.
Rizzo JD, et al. (2006) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Bone Marrow Transplant 37: 249–261.
Robison, L.L., D.M. Green, et al. (2005). "Long-term outcomes of adult survivors of childhood cancer. " Cancer 104 (11 Suppl): 2557-64.
Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K, American Society of Clinical O. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010;28(5):893-901.
Sanki, A., Kroon, H. M., Kam, P. C., & Thompson, J. F. Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities. Curr Probl Surg, 48(6), 371-430.
Schagen, S.B., M.J. Muller, et al. (2006). "Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. " J Natl Cancer Inst 98(23): 1742-5.
Schagen, S.B.and F.S. van Dam (2006). "Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?" J Clin Oncol 24(32): 5170-1; author reply 5171-2.
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
Sieniawski, M., Reineke, T., Josting, A., Nogova, L., Behringer, K., Halbsguth, T., Fuchs, M., Diehl, V., Engert, A. (2008). Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. Annals of Oncology, 19(10):1795-1801.
Simon, B., S.J. Lee, et al. (2005). "Preserving fertility after cancer. " CA Cancer J Clin 55 (4): 211-28; quiz 263-4.
Skolarus, T. A., Wolf, A. M., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., 3rd, . . . Cowens-Alvarado, R. L. (2014). American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin, 64(4), 225-249.
Sleijfer, S.(2001). "Bleomycin-induced pneumonitis. " Chest 120 (2): 617-24.
Stapleton, S.and S. Blaney (2006). "New agents for intrathecal administration. " Cancer Invest 24(5): 528-34.
Steingart, R. M., Yadav, N., Manrique, C., Carver, J. R., & Liu, J. (2013). Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management. Semin Oncol, 40(6), 690-708.
Steinherz, L.J., P.G. Steinherz, et al. (1991). "Cardiac toxicity 4 to 20 years after completing anthracycline therapy. " Jama 266 (12): 1672-7.
Stubblefield, MD & O?Dell, MW (2009) Cancer Rehabilitation Principles and Practice. New York: Demos Medical.
Sugimura, H.and P. Yang (2006). "Long-term survivorship in lung cancer: a review. " Chest 129 (4): 1088-97.
Sylatron Package Insert
Thomson, A.B., H.O. Critchley, et al. (2002). "Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. " Best Pract Res Clin Endocrinol Metab 16 (2): 311-34.
Tichelli A, et al. on behalf of the EBMT Late Effects Working Party. (2008) Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 93(8): 1203-1210.
Tichelli A, et al. (2007) Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110: 3463–3471.
Vardy, J., S. Rourke, et al. (2007). "Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research." J Clin Oncol 25(17): 2455-63.
Vaughn, D.J.and A.T. Meadows (2002). "Cancer survivorship research: the best is yet to come." J Clin Oncol 20 (4): 888-90.
Vaughn, D.J., Gignac, G.A., Meadows, A.T. (2002). Long-term medical care of testicular cancer survivors. Annals of Internal Medicine, 136(6):463-470.
Wallace, W.H.and R.A. and erson (2006). "Cancer survivors and infertility: where do we go from here?" J Support Oncol 4 (4): 183-4.
Wong, P.W., N. Macris, et al. (1998). "Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature. " Chest 113 (2): 548-50.
Woodward WA, Strom EA, McNeese MD, Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy.Int J Radiat Oncol Biol Phys.2003;57:327-35.
Yahalom, J. and Portlock, C.S. (2008). Long-term cardiac and pulmonary complications of cancer therapy. Hematology Oncology Clinics of North America, 22(2):305-318, vii.
Yarbro, C., et al. (2005). “Cancer Nursing-Principles and Practice” (6th edition). Jones and Bartlett Publishers, Boston.
Yabroff, K.R., W.F. Lawrence, et al. (2004). "Burden of illness in cancer survivors: findings from a population-based national sample. " J Natl Cancer Inst 96 (17): 1322-30.
Younes, A., Bartlett, N.L., Leonard, J.P., Kennedy, D.A., Lynch, C.M., Sievers, E.L., Forero-Torres, A. (2010). Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. New England Journal of Medicine, 363(19):1812-1821.
Zevalin Package Insert
Zoltick, B.H., L.A. Jacobs, et al. (2005). "Cardiovascular risk in testicular cancer survivors treated with chemotherapy: incidence, significance, and practice implications. " Oncol Nurs Forum 32 (5): 1005-9; quiz 1010-1.